SNTI — Senti Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Senti Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	30.5	56	98.6	35.9	48.3
Net Total Accounts Receivable
Net Total Receivables	0.317	0.483	0.626	17.7	1.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets	31.7	60.2	103	71.2	59
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.1	33.1	74.6	41.6	35.2
Long Term Notes Receivable
Other Long Term Assets
Total Assets	48.3	96.7	181	119	97.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.87	14.5	18.1	12.7	13.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.4	36.3	53.5	52.6	47.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	30.9	60.4	127	66.9	50.8
Total Liabilities & Shareholders' Equity	48.3	96.7	181	119	97.8
Total Common Shares Outstanding